DURHAM, N.C. and IPSWICH, Mass. -- EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation tools for epigenomics research. Building on a successful track record of collaboration, the partnership will accelerate the creation of innovative technologies that advance understanding of gene regulation, chromatin biology, and disease mechanisms. The partnership combines EpiCypher's strengths [...]

Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab. NGI Stockholm has become the first official core laboratory and service provider globally to offer Epigenica’s EpiFinder™ platform. This milestone represents a significant step in [...]

RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory. In this role, Mr. Porreca is responsible for leading quality assurance, quality systems [...]

MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a biotechnology company pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically defined, universal foundation medium designed to streamline organoid culture workflows while enhancing reproducibility, scalability, and cost efficiency. As organoid models continue to expand across disease modeling, drug discovery, and precision [...]

The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy Expands the ability to model human pathogenesis and functional recovery for neurodegenerative diseases NEW ORLEANS -- 28bio today announced CNS-3D Inflammatory Organoids, designed to evaluate efficacy of anti-inflammatory drugs by quantifying their ability to reduce inflammatory injury, preserve tissue health, [...]

OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO -- Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate [...]

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes SAN FRANCISCO -- Blank Bio, an applied AI research lab training foundation models for RNA, today announced the closing of a $7.2 million seed financing and a strategic collaboration with Pacific Biosciences (Nasdaq: PACB), a leading developer of high-quality, [...]

Company appoints Sam Ropp as Chief Commercial Officer and Susan Tousi to Board of Directors BOSTON -- Atrandi Biosciences, a life science tools company pioneering Semi-Permeable Capsule (SPC) technology for single-cell and multiomics research, today announced the appointment of Sam Ropp, PhD, as Chief Commercial Officer and Susan Tousi as Chairman of the Board of Directors. [...]

17-Year Multiomics Pioneer Powers Next Era of Precision Health MOUNTAIN VIEW, Calif. -- Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel. These [...]

PARIS -- #AI--Gustave Roussy partners with One Biosciences, a techbio company that harnesses single cell technology and AI to develop advanced precision diagnostics. The collaboration aims to further demonstrate the feasibility and impact of integrating single nuclei transcriptomic analysis into the patient care pathway. Gustave Roussy, Europe’s leading cancer center, is teaming up with One [...]